• Explore /
  • Poster
  • / Randomized phase III trial of concurrent chemoradiation followed by nivolumab or placebo for locally advanced non-small cell lung cancer (NSCLC) (RTOG 3505).

Randomized phase III trial of concurrent chemoradiation followed by nivolumab or placebo for locally advanced non-small cell lung cancer (NSCLC) (RTOG 3505).

Abstract Poster

Authors

David Gerber

David E. Gerber

The University of Texas Southwestern Medical Center, Dallas, TX

David E. Gerber , James John Urbanic , Corey J. Langer , Chen Hu , I-Fen Chang , Bo Lu , Benjamin Movsas , Robert Jeraj , Walter John Curran Jr., Jeffrey D. Bradley

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02768558

Citation

J Clin Oncol 35, 2017 (suppl; abstr TPS8579)

DOI

10.1200/JCO.2017.35.15_suppl.TPS8579

Abstract #

TPS8579

Poster Bd #

313a

Abstract Disclosures

Similar Posters

First Author: John M. Varlotto

First Author: Luis G. Paz-Ares

First Author: Mustafa Özgüroğlu

First Author: Christos Chouaid